Surgical Science Sweden AB Capital Reinvestment Ratio
Surgical Science Sweden AB capital reinvestment ratio. Surgical Science Sweden AB (SUS) has a Capital Reinvestment Ratio of 0.52x as of June 2026, meaning it reinvests 1% of its operating cash flow (Skr15.31 Million) in capital expenditures (Skr7.96 Million). See Surgical Science Sweden AB free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Surgical Science Sweden AB (2015–2025)
Capital reinvestment ratio of Surgical Science Sweden AB from 2015 to 2025. This chart tracks Surgical Science Sweden AB's Capital Reinvestment Ratio across 11 annual periods. See Surgical Science Sweden AB (SUS) flexibility index to measure the company's free cash flow as a share of total liabilities.
Surgical Science Sweden AB Capital Reinvestment Ratio by Year (2015–2025)
Surgical Science Sweden AB capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see SUS cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | Skr79.80 Million | Skr11.68 Million | ▼ -57.7% |
| 2024 | 0.35x | Skr137.22 Million | Skr47.53 Million | ▲ +87.0% |
| 2023 | 0.19x | Skr238.29 Million | Skr44.13 Million | ▼ -30.6% |
| 2022 | 0.27x | Skr129.49 Million | Skr34.55 Million | ▼ -27.5% |
| 2021 | 0.37x | Skr39.08 Million | Skr14.38 Million | ▼ -1.7% |
| 2020 | 0.37x | Skr23.23 Million | Skr8.69 Million | ▲ +131.8% |
| 2019 | 0.16x | Skr55.20 Million | Skr8.91 Million | ▼ -87.1% |
| 2018 | 1.26x | Skr6.88 Million | Skr8.64 Million | ▼ -17.7% |
| 2017 | 1.53x | Skr7.94 Million | Skr12.12 Million | ▲ +74.8% |
| 2016 | 0.87x | Skr13.40 Million | Skr11.70 Million | ▼ -21.1% |
| 2015 | 1.11x | Skr7.50 Million | Skr8.30 Million | — |